Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia
- PMID: 31809628
- DOI: 10.1080/10428194.2019.1697813
Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia
Similar articles
-
Importance of Acute Lymphoblastic Leukemia-type Therapy for Bilineal Acute Leukemia.J Pediatr Hematol Oncol. 2019 Aug;41(6):504-506. doi: 10.1097/MPH.0000000000001309. J Pediatr Hematol Oncol. 2019. PMID: 30198961
-
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia.Leuk Lymphoma. 2016 Jul;57(7):1527-33. doi: 10.3109/10428194.2016.1160085. Leuk Lymphoma. 2016. PMID: 27269126 Free PMC article. Review.
-
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23. J Clin Oncol. 2013. PMID: 24062400 Clinical Trial.
-
Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?Am Soc Clin Oncol Educ Book. 2016;35:e302-12. doi: 10.1200/EDBK_161258. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249736
-
Clinical Use of Measurable Residual Disease in Acute Myeloid Leukemia.Curr Treat Options Oncol. 2019 Mar 14;20(4):28. doi: 10.1007/s11864-019-0627-4. Curr Treat Options Oncol. 2019. PMID: 30874904 Review.
Cited by
-
Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis.Front Oncol. 2022 May 11;12:906370. doi: 10.3389/fonc.2022.906370. eCollection 2022. Front Oncol. 2022. PMID: 35646683 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
